BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35913890)

  • 1. Implementation of an integrated pharmacist collaborative care model in specialty disease state clinics.
    Stroedecke N; Lee J; Stutsky M; Boothe K; Tong K; Luon S; Sawant V; Renauer M
    Am J Health Syst Pharm; 2022 Nov; 79(22):2047-2052. PubMed ID: 35913890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of an integrated ambulatory care pharmacist collaborative care workflow model in specialty clinics in a large academic health system.
    Lee J; Tong K; Stroedecke N; Monestime S; Eom E; Stutsky M; Boothe K; Luon S; Sawant V; Renauer M
    Am J Health Syst Pharm; 2023 Jun; 80(13):842-851. PubMed ID: 37144568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing Patient Care Through Specialty Pharmacy Services in an Academic Health System.
    Bagwell A; Kelley T; Carver A; Lee JB; Newman B
    J Manag Care Spec Pharm; 2017 Aug; 23(8):815-820. PubMed ID: 28737983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-system specialty pharmacy role and outcomes: A review of current literature.
    Zuckerman AD; Whelchel K; Kozlicki M; Simonyan AR; Donovan JL; Gazda NP; Mourani J; Smith AM; Young L; Ortega M; Kelley TN
    Am J Health Syst Pharm; 2022 Oct; 79(21):1906-1918. PubMed ID: 35916907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pharmacist-driven referral to increase specialty pharmacy prescription capture.
    Elchehimi S; Blackwell J; Mohiuddin S; Bajaj P
    Am J Health Syst Pharm; 2024 May; 81(Supplement_2):S61-S71. PubMed ID: 38512814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of embedding a pharmacist in a dermatology clinic on outcomes in a specialty pharmacy.
    Penick T; Hawkins T; O'Reilly E; Maniyar H; Maier C; McPheeters C
    J Am Pharm Assoc (2003); 2023; 63(2):661-666. PubMed ID: 36464555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services.
    Zuckerman AD; Mourani J; Smith A; Ortega M; Donovan JL; Gazda NP; Tong K; Simonson D; Kelley T; DeClercq J; Choi L; Pierce G
    Am J Health Syst Pharm; 2023 Jun; 80(13):827-841. PubMed ID: 36999452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droxidopa management by an integrated health-system specialty pharmacy team.
    Livezey SN; Shah NB; DeClercq J; Keefe J; Choi L; Shibao C; Zuckerman AD
    J Am Pharm Assoc (2003); 2022; 62(6):1904-1911. PubMed ID: 35787811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, implementation, and evaluation of a health outcomes and research program at an integrated health-system specialty pharmacy.
    Zuckerman AD; Shah NB; Peter ME; Jolly JA; Kelley TN
    Am J Health Syst Pharm; 2021 May; 78(11):972-981. PubMed ID: 33693451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging quality improvement principles in comprehensive medication management pharmacy practice: A case example.
    Ekstrand MJ; Kobany JM; Pestka DL
    J Am Pharm Assoc (2003); 2020; 60(3):509-515.e1. PubMed ID: 31866385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of an Integrated Health System Specialty Pharmacy on HIV Antiretroviral Therapy Adherence, Viral Suppression, and CD4 Count in an Outpatient Infectious Disease Clinic.
    Barnes E; Zhao J; Giumenta A; Johnson M
    J Manag Care Spec Pharm; 2020 Feb; 26(2):95-102. PubMed ID: 32011966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-system specialty pharmacy: Overview of a hybrid clinical model.
    Meadors C; McPheeters C; Maier C; O'Reilly E
    Am J Health Syst Pharm; 2024 Apr; 81(9):e256-e260. PubMed ID: 38146967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a New Clinic-Based, Pharmacist-Managed PCSK9 Inhibitor Consultation Service.
    Atanda A; Shapiro NL; Stubbings J; Groo V
    J Manag Care Spec Pharm; 2017 Sep; 23(9):918-925. PubMed ID: 28854074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in safety monitoring of biologic response modifiers after the implementation of clinical care guidelines by a specialty.
    Hanson RL; Gannon MJ; Khamo N; Sodhi M; Orr AM; Stubbings J
    J Manag Care Pharm; 2013; 19(1):49-67. PubMed ID: 23383700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of telehealth for first-dose device teaching within a health-system specialty pharmacy.
    Buechel M; Friestrom E; Hartkopf K; Langley J
    Am J Health Syst Pharm; 2023 Jan; 80(1):e18-e22. PubMed ID: 36153818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a medication therapy management collaborative within a pediatric health system.
    Sneed G; Kappeler K; Gilmore T; Kuhn C
    J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provision of ambrisentan from a health-system specialty pharmacy affiliated with a pulmonary hypertension Center of Comprehensive Care.
    Gutenschwager DW; Patel A; Soyad AT; Patel S; Szandzik EG; Kelly B; Smith ZR
    Am J Health Syst Pharm; 2024 Jan; 81(2):66-73. PubMed ID: 37611180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of provider satisfaction with specialty pharmacy services in integrated health-system and external practice models: A multisite survey.
    Anguiano RH; Zuckerman AD; Hall E; Diamantides E; Kumor L; Duckworth DL; Peter M; Sorgen PJ; Nathanson A; Kandah HM; Dura J; Campbell U
    Am J Health Syst Pharm; 2021 May; 78(11):962-971. PubMed ID: 33677493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best practices in specialty pharmacy management.
    Patterson CJ
    J Manag Care Pharm; 2013; 19(1):42-8. PubMed ID: 23383699
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.